Manifestations of Diseases / Sequelae (DM, Stroke, COPD, Trauma)

🔍 Definition

A sequela (plural: sequelae), also historically termed a late effect, is a residual condition or complication that arises as the direct result of a prior disease or injury after the acute phase has ended. Per ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, Section I.B.10, “A sequela is the residual effect (condition produced) after the acute phase of an illness or injury has terminated.” There is no time limit on when a sequela code may be assigned — the condition may appear soon after the precipitating event or many months to years later.

A manifestation is a clinical sign, symptom, or complication that arises as a direct result of an underlying disease process. In ICD-10-CM, manifestations of diseases are coded using the etiology/manifestation convention: the underlying disease (etiology) is coded first, and the associated manifestation is coded second. The Alphabetic Index signals this pairing by listing manifestation codes in [brackets], meaning the bracketed code cannot be reported as a principal diagnosis.

Key conditions covered in this guide:

• Diabetes Mellitus (DM): Combination codes (E11.2x–E11.8x) capture DM with specific manifestations (nephropathy, neuropathy, retinopathy, foot ulcer, etc.).
• Stroke / Cerebrovascular Disease: Sequelae of cerebrovascular disease (I69.x) represent residual neurological deficits after the acute event has resolved.
• COPD: Combination codes (J44.0, J44.1) capture COPD with acute lower respiratory infection or acute exacerbation; for J44.0, code also the specific lower respiratory infection (and any causative organism when required by the infection code’s instructions).
• Trauma: 7th character extensions on injury codes (A = initial encounter, D = subsequent encounter, S = sequela) capture the phase of care for traumatic injuries and their late effects.

🗂️ Alternative Terminology

🩺 Signs & Symptoms

The clinical presentation of disease manifestations and sequelae varies significantly by the underlying condition. Coders and CDI specialists should recognize these presentations as potential indicators of codeable conditions:

Diabetic Manifestations

• Neuropathy: Burning, tingling, or numbness in feet/hands; loss of protective sensation; Charcot foot deformity; autonomic neuropathy (gastroparesis, orthostatic hypotension, neurogenic bladder)
• Nephropathy: Proteinuria, declining GFR, edema, hypertension; progression to ESRD (CKD stage 5)
• Retinopathy: Visual blurring, floaters, sudden vision loss, macular edema; nonproliferative vs. proliferative stages
• Foot ulcer / skin complications: Non-healing wounds, ulcerations of lower extremity, gangrene; deep tissue necrosis
• Circulatory: Peripheral arterial disease, claudication, absent pedal pulses, rest pain

Stroke Sequelae

• Hemiplegia or hemiparesis (dominant vs. non-dominant side documentation is critical)
• Aphasia, dysphasia, dysarthria
• Dysphagia (swallowing difficulties requiring modified diet or tube feeding)
• Cognitive deficits, vascular dementia
• Depression following stroke
• Monoplegia of upper or lower limb
• Facial weakness, diplopia, visual field defects
• Ataxia, coordination difficulties, gait disturbances

COPD Manifestations

• Chronic productive cough, dyspnea on exertion, wheezing
• Acute exacerbation: worsening dyspnea, increased sputum production, change in sputum color/character
• Hypoxemia, hypercapnia requiring supplemental oxygen or mechanical ventilation
• Cor pulmonale, right heart failure
• Respiratory failure (Type I or II)
• Signs of superimposed infection: fever, purulent sputum, consolidation on imaging

Traumatic Sequelae

• Chronic pain at fracture site or soft tissue injury location
• Malunion or nonunion of fracture
• Post-traumatic arthritis
• Contractures from burn scarring; hypertrophic or keloid scars
• Chronic traumatic brain injury (TBI) effects: headache, cognitive changes, personality changes
• Post-traumatic osteomyelitis

🧭 Differential Diagnosis

📋 Clinical Indicators

🦴 Anatomy & Pathophysiology

Sequelae and Pathophysiologic Mechanisms: Sequelae arise because tissue damage from the primary disease or injury is permanent or only partially reversible. The underlying mechanisms include:

• Neuronal death (stroke): After ischemic infarction, neurons in the ischemic core die within minutes; the penumbra may recover with reperfusion. Permanent motor, sensory, or cognitive deficits reflect the permanent neuronal loss. Residual hemiplegia, aphasia, or dysphagia are structural sequelae of the irreversible infarct per NCBI StatPearls — Cerebral Infarction.
• Microvascular disease (DM): Chronic hyperglycemia causes glycation of basement membranes, endothelial dysfunction, and advanced glycation end-products (AGEs), leading to the classic triad of retinopathy, nephropathy, and neuropathy. These manifestations are direct complications of persistent DM and are coded as combination codes in ICD-10-CM per American Diabetes Association — Complications of Diabetes.
• Airway remodeling (COPD): Chronic inflammation and repeated injury from cigarette smoke, air pollution, and recurrent infections cause irreversible destruction of alveoli (emphysema) and chronic airway inflammation (bronchitis). Exacerbations represent acute decompensation superimposed on chronic remodeling per the GOLD 2026 Report.
• Fibrotic repair (burns/trauma): After thermal injury or mechanical trauma, healing proceeds through inflammation, proliferative, and remodeling phases. Hypertrophic scar, keloid, or contracture formation represents disordered extracellular matrix deposition as a late complication of the original injury per NCBI StatPearls — Burn Wound Healing.

Etiology/Manifestation Convention in ICD-10-CM: The Alphabetic Index uses [brackets] to indicate manifestation codes that must always be sequenced second, after the etiology code. The underlying condition (etiology) drives the DRG assignment, HCC weight, and risk adjustment. Manifestation codes identified in brackets are never principal diagnosis on any claim.

💊 Medication Impact / Treatment

Medications used for underlying diseases often provide evidence supporting the presence of manifestations and sequelae. Coders and CDI specialists should recognize drug–diagnosis linkages:

Diabetes Manifestations

• ACE inhibitors / ARBs (lisinopril, losartan): first-line renoprotective agents in diabetic nephropathy — document CKD stage and link to DM (E11.22 + N18.x)
• Gabapentin / pregabalin / duloxetine: indicate diabetic peripheral neuropathy (E11.40–E11.49)
• Bevacizumab (Avastin) / anti-VEGF injections: treat diabetic macular edema — link to the documented diabetic retinopathy type, severity, laterality, and macular edema status (e.g., E11.311 for unspecified diabetic retinopathy with macular edema; E11.3211 for mild nonproliferative diabetic retinopathy with macular edema, right eye)
• Wound care orders / debridement: support diabetic ulcer coding when provider linkage is documented (E11.621 for diabetic foot ulcer + L97.x for site/depth; E11.622 for other diabetic skin ulcer + L97.x as applicable)
• Insulin use: code Z79.4 (long-term insulin use) for Type 2 DM on insulin per CMS Guidelines Section I.C.4.a.3

Stroke Sequelae

• Physical therapy, occupational therapy, speech therapy orders: indicate active treatment of sequelae (hemiplegia, aphasia, dysphagia)
• Anticoagulation (warfarin, DOACs): may be for atrial fibrillation (cause of cardioembolic stroke) or DVT prophylaxis post-stroke; code underlying condition
• Antispasmodics (baclofen, tizanidine): indicate spasticity as sequela of stroke (I69.398 or I69.343)
• PEG tube/gastrostomy: supports dysphagia due to sequela (I69.391)

COPD

• Home oxygen therapy (Z99.81): documents dependence on supplemental oxygen; review for provider-documented chronic hypoxemic respiratory failure, but do not code J96.11 unless respiratory failure is documented
• Systemic corticosteroids: indicate acute exacerbation (J44.1)
• Antibiotics: if given for COPD exacerbation with identified respiratory pathogen, supports J44.0 + specific organism code
• Bronchodilators (LAMA/LABA combinations): maintenance therapy; does not by itself indicate exacerbation
• Non-invasive positive pressure ventilation (BiPAP): supports review for acute respiratory failure, but code J96.0- or J96.2- only when respiratory failure is documented by the provider; use J96.21 for documented acute-on-chronic respiratory failure with hypoxia and sequence per FY 2027 ICD-10-CM Guidelines Section I.C.10.b

Trauma Sequelae

• NSAIDs / opioid pain management: ongoing use at follow-up may indicate persistent pain as sequela (G89.21 post-traumatic chronic pain)
• Orthopedic hardware, revision surgery: late complication of fracture — use complication of internal fixation device codes (T84.xxx) vs. malunion codes (M84.3x)
• Compression garments, scar therapy: burn scar management — supports sequela coding (L90.5, T-code with 7th S)

Preview ends here. The full guide continues with FY2027 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides

📘 ICD-10-CM Guidelines

The following official guidelines govern sequela and manifestation coding per the FY 2027 ICD-10-CM Official Guidelines for Coding and Reporting (CMS/NCHS):

Section I.B.10 — Sequelae (Late Effects)

A sequela is the residual effect produced after the acute phase of an illness or injury has terminated. There is no time limit on when a sequela code may be used; the residual may be apparent early or may occur many months or years later. Examples: scar formation after a burn; deficits from CVA; residual weakness from encephalitis.

• Sequencing rule: Code first the condition or nature of the sequela (the residual), then the cause of the sequela (the sequela code itself). Example: hemiplegia (I69.351) coded before sequela of cerebral infarction (if using expanded I69 code).
• Exception 1: When the sequela code itself has been expanded (at 4th, 5th, or 6th character) to include the manifestation, only the one code is needed. Example: I69.351 (Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side) includes both the residual and the cause in a single code.
• Exception 2: When the sequela code identifies the etiology at the 4th character level, no separate residual code is needed.

Section I.A.13 — Etiology/Manifestation Convention

Certain conditions have both an underlying etiology and multiple body system manifestations. The Alphabetic Index signals these relationships by placing manifestation codes in [brackets]. The tabular list includes instructional notes such as “Code first underlying disease” or “Use additional code.” Key rules:

• The etiology code is always sequenced first; the manifestation code second — this sequencing is mandatory and is not a “coder preference.”
• Manifestation codes in brackets can never be sequenced as a principal or first-listed diagnosis.
• The convention applies to conditions such as: DM with renal manifestation (E11.xx → N18.x), Alzheimer’s with dementia (G30.x → F02.8x), Parkinson’s with dementia (G20.x → F02.8x).

Section I.C.4 — Diabetes Mellitus

• Assign the most specific combination code. Do not code DM + manifestation as two separate codes if a combination code exists.
• Assume Type 2 if type is not documented (E11.x default per guidelines).
• Add Z79.4 for long-term insulin use when a Type 2 DM patient routinely uses insulin; also add Z79.84 for long-term oral hypoglycemic use and/or Z79.85 for long-term injectable non-insulin antidiabetic use when applicable. Do not assign Z79.4 for Type 1 diabetes when insulin use is inherent, or when insulin is given temporarily to bring a Type 2 patient’s blood sugar under control during an encounter.
• For DM + CKD: code E11.22 + N18.x (CKD stage). Query for CKD stage if not documented.
• For DM + foot ulcer: code E11.621 (Type 2 diabetes mellitus with foot ulcer) + L97.x for ulcer location, laterality, and severity/depth. Use E11.622 for Type 2 diabetes mellitus with other skin ulcer, not as a left-foot-ulcer code.
• Multiple manifestations: code each applicable complication subcode (e.g., E11.40 + E11.22 + Z79.4).

Section I.C.9.d — Cerebrovascular Disease

• Category I63 (Cerebral infarction) is for the acute event only. Do not use I63.x when the acute phase has ended.
• Category I69 (Sequelae of cerebrovascular disease) is used when there are neurological deficits remaining after the acute phase. Subcategory I69.3 covers sequelae of cerebral infarction.
• Side documentation is critical: I69.351 = right dominant, I69.352 = left dominant, I69.353 = right non-dominant, I69.354 = left non-dominant. Query the provider when laterality and dominance are not documented.
• If a patient has acute CVA AND residual deficits from a prior CVA in the same admission, code both I63.x and I69.3xx.
• Z86.73 = personal history of TIA; use only when there are no residual neurological deficits.

Section I.C.10 — COPD / Respiratory

• J44.0 = COPD with acute lower respiratory infection; CODE ALSO the infection (J12–J18 for pneumonia, J20 for acute bronchitis). J44.0 is sequenced first per instructional note.
• J44.1 = COPD with (acute) exacerbation — used when documented as “acute exacerbation” or “AECOPD” without a confirmed superimposed infection.
• When acute respiratory failure is present with COPD exacerbation, sequence COPD first or respiratory failure first depending on the circumstances of admission per guidelines (principal diagnosis = condition most responsible for admission).
• J44.81 = Bronchiolitis obliterans and bronchiolitis obliterans syndrome. Do not use J44.81 for asthma-COPD overlap; for asthma with COPD/chronic obstructive asthma, assign the appropriate J44.- code and code also the type of asthma (J45.-), if applicable.

Section I.C.19 — Trauma / Injury Coding (7th Character Rules)

• 7th character A = Initial encounter — patient is receiving active treatment for the condition. Applies during ER visit, surgical procedure, or any active management of the injury.
• 7th character D = Subsequent encounter — patient has received active treatment; now receiving routine care during healing/recovery phase.
• 7th character S = Sequela — the acute injury has healed; patient now presents with a late complication or residual condition directly resulting from the injury. Sequence the specific residual condition first (e.g., scar, contracture, nonunion/malunion, post-traumatic arthritis), then the injury code with 7th character S.
• For burns: use T-codes with 7th character S for late effects; add L90.5 (scar and fibrosis of skin), M24.5x (contracture of joint), or T86.820 (burn scar) as appropriate.

🔢 ICD-10-CM Code Set (Tabular)

🔎 Indexing

Using the ICD-10-CM Alphabetic Index correctly is essential for manifestation and sequela coding. Key entry points:

Sequela / Late Effect Index Entries

• Sequelae (of) — main term; subterms by condition type (burn, cerebrovascular disease, injury, infection)
• For stroke sequelae: Index → “Sequelae, cerebrovascular disease” → leads to I69.xx category with further subterms by type of deficit
• For traumatic sequelae: Index → injury code with note “code as sequela” when in follow-up phase with residual
• For burn late effects: Index → “Sequelae, burn and corrosion” → T95.x (older ICD-9 cross-reference approach) or specific burn code + 7th S

Etiology/Manifestation Index Entries

• Diabetes, diabetic (mellitus) → subterms (neuropathy, nephropathy, retinopathy, foot ulcer, etc.) → combination codes E11.xx shown with applicable add-codes in [brackets]
• Neuropathy, diabetic → leads back to E11.40–E11.49 series
• Retinopathy, diabetic → E11.311–E11.359 with macular edema subterms
• COPD → J44.9; “with acute bronchitis” → J44.0; “with acute exacerbation” → J44.1
• Hemiplegia, following cerebrovascular disease → I69.35x with laterality/dominance subterms
• Failure, heart → I50.9; with hypertension → I11.0 (required combination)

🏥 CPT

🧾 HCPCS

📚 AHA Coding Clinic

The AHA Coding Clinic provides official guidance on ICD-10-CM/PCS coding questions. Key advisories relevant to manifestations and sequelae include:

• Centers for Medicare & Medicaid Services and National Center for Health Statistics. ICD-10-CM Official Guidelines for Coding and Reporting FY 2027, Section I.B.9; Centers for Medicare & Medicaid Services and National Center for Health Statistics. ICD-10-CM Index to Diseases and Injuries FY 2027, Edema, macula, diabetic: Diabetic macular edema is classified with a diabetic retinopathy combination code (for example, E11.311, Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema); the Index entry Edema, macula, diabetic directs to Diabetes, by type, with, retinopathy, with macular edema. Assign only the combination code when it fully identifies the conditions (Section I.B.9); category H35 has an Excludes2 note for diabetic retinal disorders (E11.311-E11.359).
• AHA Coding Clinic, 3Q 2016, “Chronic Obstructive Pulmonary Disease with Lobar Pneumonia” (corrected in AHA Coding Clinic, 2Q 2017, “Chronic Obstructive Pulmonary Disease with Acute Lower Respiratory Infection”): COPD with lobar pneumonia is coded J44.0, Chronic obstructive pulmonary disease with (acute) lower respiratory infection, with an additional code for the infection (J18.1 in the example). Coding Clinic sequenced J44.0 first based on the “use additional code to identify the infection” note in effect at that time. In the FY 2027 Tabular List, J44.0 carries a “code also to identify the infection” note, and a “code also” note does not provide sequencing direction (Official Guidelines FY 2027, Section I.A.17).
• AHA Coding Clinic, 1Q 2015, “Residual Right-Sided Weakness Due to Previous Cerebral Infarction”: Residual unilateral weakness due to a previous cerebral infarction is coded as hemiparesis from category I69 (I69.35-), and sequela codes may be used at any time after the acute phase (Official Guidelines FY 2027, Section I.B.10). When the affected side is documented but dominance is not, the default is dominant for the right side and for ambidextrous patients, and nondominant for the left side (Section I.C.9.d.1).
• AHA Coding Clinic, 1Q 2015, “Applying the 7th Characters for Injury, Poisoning and Certain Other Consequences of External Causes”: Assignment of the 7th character is based on whether the patient is undergoing active treatment, not on whether the provider is seeing the patient for the first time or on time elapsed since the injury. 7th character A is used while the patient is receiving active treatment (for example, surgical treatment, an emergency department encounter, or evaluation and continuing treatment by the same or a different physician); D is used after active treatment, during routine care in the healing or recovery phase (Official Guidelines FY 2027, Section I.C.19.a).
• AHA Coding Clinic, 3Q 2019, “Hypertension with Diabetic Nephropathy and Chronic Kidney Disease”: E11.22, Type 2 diabetes mellitus with diabetic chronic kidney disease, is assigned with a code to identify the CKD stage (N18.1-N18.6), per the Tabular “use additional code” note. When CKD is documented as due to diabetes, or as diabetic nephropathy or similar terminology, a causal relationship to diabetes is indicated; do not assign both E11.21 (diabetic nephropathy) and E11.22, because diabetic CKD is the more specific condition. When the patient also has hypertension and the provider does not attribute the CKD to a cause, the classification presumes CKD is related to both, and E11.22, I12.9, and N18.- are assigned (AHA Coding Clinic, 4Q 2018, “Hypertension, Diabetes Mellitus and Chronic Kidney Disease”).
• AHA Coding Clinic, 1Q 2017, “Hypertension with Congestive Heart Failure”: ICD-10-CM presumes a causal relationship between hypertension and heart failure; assign I11.0, Hypertensive heart disease with heart failure, with an additional code from category I50 to identify the type of heart failure, unless the documentation clearly states the conditions are unrelated (Official Guidelines FY 2027, Section I.C.9.a.1).
• AHA Coding Clinic, 2Q 2024, “Asthma with COPD”: Assign J44.89, Other specified chronic obstructive pulmonary disease, for a patient with asthma and COPD. A separate J45.- code is assigned only when the type of asthma is specified or the asthma is exacerbated, per the “code also type of asthma, if applicable (J45.-)” note at category J44; do not assign J45.909 when the type of asthma is not specified. J44.81 identifies bronchiolitis obliterans and bronchiolitis obliterans syndrome and is not an asthma-COPD code.

💰 HCC / Risk Adjustment

Under the CMS-HCC Model v28 (effective 2026), accurate coding of disease manifestations and sequelae is critical for appropriate risk adjustment. Sequelae codes often carry the full HCC weight of the underlying disease category:

✍️ CDI Query Templates

All queries below are written per AHIMA/ACDIS Compliant Query Guidelines: non-leading, multiple-choice, clinically supported, and documented in the medical record.

🧑‍⚕️ Treatments (Clinical)

Diabetic Manifestations — Treatment Overview

• Diabetic nephropathy: Tight glycemic control with individualized A1C targets per ADA Standards of Care 2026, ACE inhibitors or ARBs for renoprotection when indicated, sodium-glucose co-transporter-2 (SGLT2) inhibitors (empagliflozin, dapagliflozin) shown to reduce CKD progression, eventual hemodialysis or peritoneal dialysis for ESRD.
• Diabetic neuropathy: Optimize glycemic control; pharmacologic pain management (gabapentin, pregabalin, duloxetine, tricyclics); topical capsaicin; neuropathic foot care, protective footwear, and podiatric follow-up per ADA Standards of Care 2026, Section 12.
• Diabetic retinopathy: Intravitreal anti-VEGF injections (ranibizumab, aflibercept) for proliferative retinopathy and macular edema; panretinal photocoagulation laser therapy; vitrectomy for advanced disease.
• Diabetic foot ulcer: Wound debridement (CPT 11042/11043), offloading (total contact cast), bioengineered skin substitutes, negative pressure wound therapy (VAC), vascular surgery consultation for PAD, osteomyelitis management if bone involved.

Stroke Sequelae — Rehabilitation

• Hemiplegia/hemiparesis: Inpatient rehabilitation facility (IRF) admission when medically appropriate and able to participate; early, individualized multidisciplinary rehabilitation; physical therapy (gait training, strength), occupational therapy (ADLs, upper extremity function); constraint-induced movement therapy (CIMT) when appropriate per the AHA/ASA 2026 Guideline for Adult Stroke Rehabilitation and Recovery.
• Aphasia: Speech-language pathology, high-intensity therapy, constraint-induced aphasia therapy; augmentative/alternative communication (AAC) devices.
• Dysphagia: Modified diet textures, nasogastric or PEG tube feeding, compensatory swallowing strategies.
• Spasticity: Oral baclofen, tizanidine; botulinum toxin chemodenervation for focal extremity spasticity is typically reported from CPT 64642–64645 based on extremity and number of muscles treated; intrathecal baclofen pump for severe cases.

COPD — Acute and Chronic Management

• Acute exacerbation (AECOPD): Short-acting bronchodilators (SABA + SAMA nebulization), systemic corticosteroids when indicated (often a short course such as 5 days, per current COPD guidance), antibiotics if evidence of bacterial infection, supplemental oxygen targeting SpO2 88–92%, and noninvasive ventilation for hypercapnic respiratory failure when clinically indicated.
• Chronic COPD management: Long-acting bronchodilators (LAMA/LABA combination inhalers), inhaled corticosteroids (ICS) for frequent exacerbators (LABA/ICS/LAMA triple therapy), pulmonary rehabilitation, smoking cessation, pneumococcal and annual influenza vaccination.

Trauma Sequelae

• Malunion/nonunion of fracture: Surgical revision — corrective osteotomy, internal fixation, bone grafting; electrical bone stimulation.
• Post-traumatic arthritis: NSAIDs, intra-articular corticosteroids, eventual joint arthroplasty for severe cases.
• Burn scar/contracture: Serial splinting, pressure garments, scar massage; surgical release and skin grafting for contractures limiting function; laser therapy (fractional CO2 or PDL) for scar remodeling.

🎓 Patient Education / Summary

The following information is intended to assist clinical documentation specialists in understanding how to communicate these conditions to non-coder stakeholders and patients. This summary is not medical advice.

What Patients Should Know About Disease Complications

For Diabetic Patients: Diabetes can affect many organ systems over time. The kidneys, eyes, nerves, and circulation can all be damaged by long-term high blood sugar. Each of these complications requires specific documentation in the medical record so that insurance and Medicare can accurately reflect how complex a patient’s health situation is. Patients should know that their entire medical history matters — even “old” problems like a prior stroke or a healed fracture — because residual effects are still coded and still matter for care planning.

For Stroke Survivors: A stroke is an acute medical emergency, but the effects of a stroke — weakness, difficulty speaking, trouble swallowing — can last a lifetime. These lasting effects are called “sequelae.” It is important that these residual conditions are documented at every visit, not just when they are actively being treated. The side of the body affected (right or left) and which hand the patient uses dominantly are important details that affect coding accuracy and payment for rehabilitation services.

For Patients with COPD: COPD is a chronic disease that can worsen with infections or environmental triggers. When COPD gets worse — called a “flare-up” or exacerbation — it may require hospitalization. Whether the flare-up is caused by an infection (pneumonia, bronchitis) or by other triggers matters for how it is coded. Patients should inform their care team about any respiratory infections, changes in sputum, or increased breathing difficulty so these can be properly documented and treated.

For Trauma Patients: After an injury, medical coding uses different codes depending on where you are in the healing process. “Initial encounter” is for when you first receive treatment. “Subsequent encounter” is for follow-up during healing. “Sequela” means the injury has healed but you have a lasting complication — like a scar, stiff joint, or chronic pain. These distinctions are important for insurance coverage of rehabilitation, pain management, and surgical correction of late complications.

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY 2027 ICD-10-CM (effective October 1, 2026). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)